Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)

CAPS Rating: 1 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Recs

1
Player Avatar TerryHogan (99.92) Submitted: 1/5/2013 2:57:17 AM : Underperform Start Price: $3.88 ONCY Score: +26.53

I think they are still a long way from making money. Also, I believe their engineered virus is how the zombie apocalypse will start, so if they are successful, it won't matter for very long.

Featured Broker Partners


Advertisement